{"title": "Covid-19 dynamics in Albania: first estimates and projections", "doi": "10.1101/2020.03.20.20038141", "citation_id": "2020.03.20.20038141v1", "date": "2020-03-23", "laguage": "en", "journal_title": "medRxiv", "first_page": "2020.03.20.20038141", "abstract": "<p>Albania reported the first confirmed case of COVID-19 on the 9th of March 2020. Given very close travel connections with Italy, the most affected country in Europe from this virus so far, with a fast growing epidemic over the previous month of February, the concern over a major similar outbreak in Albania was significant. Immediately following the first confirmation, country-wide measures were taken to reduce transmission such as university and school closures, closure of bars and restaurants, prohibition of public gatherings, leading to the second-quickest major social distancing measure in any European country after Italy. The parameters governing the epidemic course of COVID-19 in Albania remain unknown, in particular the initial number of imported cases from Italy or elsewhere, but as more data are becoming available, some first estimates and projections can be made. The aim of this report is to develop a mathematical epidemiological framework for data interpretation and comparison, as they accumulate, for exploring epidemiologic and demographic aspects specific to this country, and for making preliminary projections based on the current and growing understanding of COVID-19 in Albania and around the world. Using a classical SEIR epidemiological model, fitted to the initial dynamics of cases up to March 18, I show how the estimate for initial number of exposed individuals varies between 65 and 166, depending on values of symptomatic transmission (50-60%)and incubation time (6-14) days. Quantitatively, these factors together determine the future course of number of cases, and the relative effectiveness of control efforts. In model projections, the peak of the outbreak in Albania is expected towards the end of March or first week of April, with as of yet, large uncertainty with respect to its magnitude. The results highlight that maintaining transmission-reducing measures is extremely critical to control.</p>", "twitter_description": "Albania reported the first confirmed case of COVID-19 on the 9th of March 2020. Given very close travel connections with Italy, the most affected country in Europe from this virus so far, with a fast growing epidemic over the previous month of February, the concern over a major similar outbreak in Albania was significant. Immediately following the first confirmation, country-wide measures were taken to reduce transmission such as university and school closures, closure of bars and restaurants, prohibition of public gatherings, leading to the second-quickest major social distancing measure in any European country after Italy. The parameters governing the epidemic course of COVID-19 in Albania remain unknown, in particular the initial number of imported cases from Italy or elsewhere, but as more data are becoming available, some first estimates and projections can be made. The aim of this report is to develop a mathematical epidemiological framework for data interpretation and comparison, as they accumulate, for exploring epidemiologic and demographic aspects specific to this country, and for making preliminary projections based on the current and growing understanding of COVID-19 in Albania and around the world. Using a classical SEIR epidemiological model, fitted to the initial dynamics of cases up to March 18, I show how the estimate for initial number of exposed individuals varies between 65 and 166, depending on values of symptomatic transmission (50-60%)and incubation time (6-14) days. Quantitatively, these factors together determine the future course of number of cases, and the relative effectiveness of control efforts. In model projections, the peak of the outbreak in Albania is expected towards the end of March or first week of April, with as of yet, large uncertainty with respect to its magnitude. The results highlight that maintaining transmission-reducing measures is extremely critical to control.\n\n### Competing Interest Statement\n\nThe authors have declared no competing interest.\n\n### Funding Statement\n\nNo specific funding was received for this work.\n\n### Author Declarations\n\nAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.\n\nYes\n\nAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.\n\nYes\n\nI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).\n\nYes\n\nI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.\n\nYes\n\nAll data are publicly available, provided by the WHO.\n\n<https://ourworldindata.org/coronavirus>", "full_text_html_url": "https://www.medrxiv.org/content/10.1101/2020.03.20.20038141v1.full", "public_url": "https://www.medrxiv.org/content/10.1101/2020.03.20.20038141v1", "abstract_html_url": "https://www.medrxiv.org/content/10.1101/2020.03.20.20038141v1.abstract", "pdf_url": "https://www.medrxiv.org/content/medrxiv/early/2020/03/23/2020.03.20.20038141.full.pdf", "rights": "\u00a9 2020, Posted by Cold Spring Harbor Laboratory. This pre-print is available under a Creative Commons License (Attribution-NonCommercial-NoDerivs 4.0 International), CC BY-NC-ND 4.0, as described at http://creativecommons.org/licenses/by-nc-nd/4.0/", "publisher": "Cold Spring Harbor Laboratory Press", "pisa": "medrxiv;2020.03.20.20038141v1", "access_rights": "restricted", "authors": ["Erida Gjini"]}